Stock screener

KRYS

Conviction 100HealthcareScan · Thu, Jun 25, 2026
KRYS$359.88+3.52%
ResistanceSupportVol 14Insider sell
63 bars
22
Vol MA14 415.28K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Krystal Biotech, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.krystalbio.com ↗
Price359.88
Change+3.52%
Gap+0.70%
Rel volume3.03×
Avg volume365.84K
Avg $ vol120.08M
SMA 20320.68
SMA 50300.76
SMA 200248.17
Price vs 50+19.66%
Price vs 200+45.01%
MA stackbullish
50/200 cross—
Supertrendup · 315.82
RSI (14)74
MACD hist3.29
MACD crossbull · 9d
Stoch %K / %D96 / 85
ADX (14)32
+DI / −DI37 / 11
RSI divergence—
MACD divergence—
ATR %+3.52%
ADR %3.84%
52w high359.88
52w low134.94
From 52w high+0.00%
Above 52w low+166.69%
New 52w highYes
SqueezeOff
Bollinger width23.91%
%B1.01
Donchian pos97.09%
Donchian high362.12
Donchian low285.07
AVWAP (52w high)356.51
vs AVWAP high+0.94%
AVWAP (52w low)234.53
vs AVWAP low+53.45%
OBV trendUp
Chaikin MF (20)-0.01
Today vs 20d3.03×
Avg vol (14d)415.28K
Avg vol (20d)365.84K
Avg $ vol (20d)120.08M
Market cap10.61B
RS 3m (vs SPY)+28.43%
RS 6m (vs SPY)+36.63%
RS line new highYes
Trend template8/8
Technical rank91.9
1 week+5.33%
1 month+18.90%
3 months+41.16%
6 months+44.17%
1 year+150.49%
YTD+45.75%
P/E51.79
P/B8.31
P/S27.26
P/FCF56.16
EPS6.84
Div yield—
ROE16.04%
ROA14.66%
Debt/Eq0.00
Current9.46
EV/EBITDA61.15
Gross margin—
Net margin52.64%
Rev growth33.94%
EPS growth129.74%
Price target340.50
Target upside-5.38%
Analyst ratingBuy
Institutional106.82%
Ent. value10.11B
Revenue116.36M
Net income55.93M
Gross profit—
Free cash flow188.91M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out29.48M
Employees295
ListedWed, Sep 20, 2017
Free float23.93M
Float %81.3%
Short interest3.15M
Days to cover16.2d
Short volume71.7%
Squeeze score86 / 100
Next earningsMon, Aug 3, 2026 (39d)
EPS forecast$1.80 · 3 est
Last EPS vs est$1.83 vs $1.45
Last surprise+26.2% beat
Setup gradeA+
Conviction100 / 100
Pattern quality—
Tech rank91.9 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance344.00
Support265.85
Days since event—
Candle confirm—
News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 17 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

  1. Broke out
    Jun 1
    1 scan
  2. Setting up
    Jun 9
    1 scan

Congress activity

Disclosed STOCK Act trades in KRYS

All disclosures →
No recent disclosed trades by Congress in KRYS. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in KRYS · 9 sells

InsiderSideShares
Krishnan Suma
President, R&D · Common Stock · 2026-06-04
Sell12.73K
Krishnan Krish S
President and CEO · Common Stock · 2026-06-04
Sell964
Krishnan Krish S
President and CEO · Common Stock · 2026-06-04
Other—
Krishnan Krish S
President and CEO · Common Stock · 2026-06-04
Sell589
Krishnan Krish S
President and CEO · Common Stock · 2026-06-04
Sell320
Krishnan Suma
President, R&D · Common Stock · 2026-06-04
Sell400
Krishnan Suma
President, R&D · Common Stock · 2026-06-04
Sell480
Krishnan Krish S
President and CEO · Common Stock · 2026-06-04
Sell2.65K
Krishnan Krish S
President and CEO · Common Stock · 2026-06-04
Sell2.78K
Krishnan Suma
President, R&D · Common Stock · 2026-06-04
Sell3.8K

SEC filings

EDGAR filings in KRYS · 3 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.